NCT00002482 2013-11-06
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
National Cancer Institute (NCI)
Cambridge Antibody Technology
Cambridge Antibody Technology
GammaCan